within Pharmacolibrary.Drugs.ATC.C;

model C03DB01
  extends Pharmacokinetic.Models.PK_1C_enteral(
    weight         = 70,
    F              = 0.5,
    Cl             = 0.005,
    adminDuration  = 600,
    adminMass      = 10 / 1000000,   // mg → kg
    adminCount     = 1,
    Vd             = 0.018,
    Cmin           = 0.001,
    Cmax           = 0.01,
    Ctox_peak      = 0.02,
    Ctox_trough    = 0.01,
    ka             = 0.005333333333333333,
    Tlag           = 10.200000000000001
  );

  annotation (Documentation(
    info       = "<html><body><table><tr><td>Drug:</td><td>C03DB01</td></tr><td>route:</td><td>oral</td></tr><tr><td>n-compartments</td><td>1</td></tr></table><p>Amiloride is a potassium-sparing diuretic primarily used in the management of hypertension and congestive heart failure. It acts by inhibiting sodium reabsorption in the distal convoluted tubule and collecting duct, thus reducing potassium excretion. Amiloride is approved and currently used clinically, often in combination with other diuretics.</p><h4>Pharmacokinetics</h4><p>Pharmacokinetic parameters reported for healthy adult volunteers following oral administration (single-dose studies).</p><h4>References</h4><ol><li><p>Jones, KM, et al., &amp; Dukes, GE (1997). Pharmacokinetics of amiloride after inhalation and oral administration in adolescents and adults with cystic fibrosis. <i>Pharmacotherapy</i> 17(2) 263–270. PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/9085317/&quot;>https://pubmed.ncbi.nlm.nih.gov/9085317</a></p></li><li><p>Brooks, SG, et al., &amp; Shaw, HL (1984). Pharmacokinetics of an oral frusemide/amiloride combination tablet. <i>Current medical research and opinion</i> 9(2) 141–146. DOI:<a href=&quot;https://doi.org/10.1185/03007998409109572&quot;>10.1185/03007998409109572</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/6399890/&quot;>https://pubmed.ncbi.nlm.nih.gov/6399890</a></p></li><li><p>Segre, G, et al., &amp; Giorgi, G (1998). Amiloride pharmacokinetics in rat. <i>European journal of drug metabolism and pharmacokinetics</i> 23(2) 218–222. DOI:<a href=&quot;https://doi.org/10.1007/BF03189343&quot;>10.1007/BF03189343</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/9725485/&quot;>https://pubmed.ncbi.nlm.nih.gov/9725485</a></p></li></ol></body></html>",
    revisions  = "<html><body><ul><li>06/2025 initial model generated by LLM gpt-4.1 from general data</li></ul></body></html>"
  ));
end C03DB01;
